Irvine, Calif., Aug. 2, 2021 — From cutting-edge research for advancing precision medicine to an innovative new effort for improving public water infrastructure to increase conservation, University of California, Irvine scholars, scientists and physicians are blazing new paths to help change the world. And their impact keeps growing.
Cardiovascular physicians with UC San Diego Health have joined an international clinical trial utilizing a new Extravascular Implantable Cardioverter-Defibrillator (EV ICD) system to help treat sudden cardiac arrest.
Intranasal vaccination is needle-free and elicits immunity at the site of infection, the respiratory tract
A University of Arizona Health Sciences study of COVID-19 vaccine effectiveness and immunity among frontline workers has received a $15 million award from the U.S. Centers for Disease Control and Prevention (CDC) to continue the current research for another year…
MUSC Hollings Cancer Center part of promising clinical trial for aggressive lymphoma
Team identifies crucial interaction between platelets and tumors for the first time
Geneticists from Trinity College Dublin have discovered how a specific genetic mutation called H3K27M causes a devastating, incurable childhood cancer, known as diffuse midline glioma (DMG), and – in lab studies working with model cell types – successfully reverse its…
Researchers are the first to model COVID-19 completion versus cessation in clinical trials using machine learning algorithms and ensemble learning. They collected 4,441 COVID-19 trials from ClinicalTrials.gov to build a testbed with 693 dimensional features created to represent each clinical trial. These computational methods can predict whether a COVID-19 clinical trial will be completed or terminated, withdrawn or suspended. Stakeholders can leverage the predictions to plan resources, reduce costs, and minimize the time of the clinical study.
Drug blocks a cell receptor that is mutated disproportionately in people of color
New Rochelle, NY, July 21, 2021– Evaluating the efficacy of novel therapies requires the ability to monitor wound progression accurately and reproducibly over time. Researchers have proposed a new scoring system for wound healing in mice based on parameters in…
A new University of Chicago study has found that the drug masitinib may be effective in treating COVID-19. The drug, which has undergone several clinical trials for human conditions but has not yet received approval to treat humans, inhibited the…
July 20, 2021; Oslo, Norway and Seoul, Republic of Korea: The Coalition for Epidemic Preparedness Innovations (CEPI) and the International Vaccine Institute (IVI) today announced a new programme of clinical research which aims to expand access to COVID-19 vaccines in…
Clinical trial was conducted in the real-world setting of a workplace health plan
NIH-funded multi-year study will look at impacts on children’s physical health and quality of life
Global stakeholders come together to collaborate with urgency to address unmet needs for Parkinson’s therapies
Researchers are using computer models to simulate COVID-19 infections on a cellular level – the basic structural level of the human body.
These findings suggest that for therapies to be effective, they must be targeted at both gene products
The National Institutes of Health’s National Human Genome Research Institute award will help discover inherited rare diseases and conditions in children
15-times more likely to detect high risk patients
New Rochelle, NY, July 14, 2021-Firsthand reports from nurses in correctional facilities detail the challenges they faced during the COVID-19 pandemic. These firsthand accounts are reported in a special issue on correctional nursing in the Journal of Correctional Health Care…
Interim results of the REACH study of daily oral PrEP and monthly dapivirine vaginal ring presented at IAS 2021 – the 11th IAS Conference on HIV Science
The partnership will accelerate the development of new Tuberculosis (TB) drug regimens as part of the Innovative Medicines Initiative (IMI), a public-private European Research & Development Consortium
The coronavirus disease 2019 (COVID-19) outbreak has spread throughout the globe and much time has passed since it was declared as a pandemic by the World Health Organization (WHO). COVID-19: Diagnosis and Management provides clinicians and scholars all the information…
Today we’d like to say a big thank you to the Lott for their generous donation to the Zero Childhood Cancer Program.
Kamil Gareev, Associate Professor at ETU “LETI,” justified the prospects of using magnetotactic bacteria to treat malignant tumors.
Pioneering ‘printed metal’ procedure to create bespoke treatment for early knee osteoarthritis set to be trialled in the UK following MHRA approval. World’s first 3D printed high tibial osteotomy (HTO) device and procedure developed at University of Bath given approval…
What The Study Did: In this randomized clinical trial, a physician messaging campaign was effective in increasing COVID-19 knowledge, information-seeking and self-reported protective behaviors among diverse groups. Authors: Esther Duflo, Ph.D., of the Massachusetts Institute of Technology in Cambridge, is…
PrecISE study is now enrolling local patients and will use personalized medicine approach to test multiple therapies to treat severe asthma
International RAPID Trial could contribute to clinical practice
New Rochelle, NY, July 13, 2021–Males with COVID-19 had significantly higher rates of hospitalization and of transfer to the intensive care unit (ICU) according to a new study. A higher percentage of males died of COVID-19 compared to females, as…
Treatment with VivAer, a non-invasive, temperature-controlled, radiofrequency (RF) device, resulted in significant symptom relief, superior to sham control
Researchers at University of California San Diego School of Medicine describe a new approach that uses machine learning to hunt for disease targets and then predicts whether a drug is likely to receive FDA approval.
SK Chemicals-Standigm will collaborate for the development of Standigm’s AI-driven drug candidate
Results could help boost immunization rates during and beyond pandemic among key health care workers
Although Covid-19 affects men and women differently, the large majority of current clinical studies of SARS-CoV-2 and COVID-19 makes no mention of sex/gender. Indeed, only a fraction, 4 percent, explicitly plan to address sex and gender in their analysis, concludes…
Researchers, including academics from the University of York, analysed systematic reviews of 1,200 Randomised Controlled Trials (RCTs) to assess whether reporting had improved over time. However, the information the researchers needed to assess what adverse effects were reported (and how…
#ASTRO21 will be the first major medical conference in the city; a curated digital program also will be offered for remote attendees
Researchers at the National Cerebral and Cardiovascular Center in Japan show that excessive blood pressure reduction for acute intracerebral hemorrhage is risky in people with decreased kidney function Suita, Japan — Stroke and chronic kidney disease are both difficult to…
Interim data from a phase 3 trial of a COVID-19 vaccine developed in China (CoronaVac) suggests that two doses offer 83.5% protection against symptomatic COVID-19. The preliminary findings, published in The Lancet and presented at this year’s European Congress of…
CU researchers say the data points to a health care disparity when it comes to caring for Black mothers and their children in the U.S.
Increased heart disease prevention education and awareness needed for younger, at-risk patients
Researchers find that central anticholinergic drug trihexyphenidyl can potentially keep away post-traumatic stress disorder-related flashbacks and nightmares
Findings from a study published today [6 July] in the Journal of the American Medical Association ( JAMA ) have prompted new World Health Organization (WHO) recommendations to use interleukin-6 antagonists in patients with severe or critical COVID-19 along with…
Clinical studies of COVID-19 drugs may benefit from randomization and early recruitment, model shows
ESMO World Congress on Gastrointestinal Cancer 2021
ESMO World Congress on Gastrointestinal Cancer 2021
Existing medications can reduce severity by ‘at least 30%’
Scientists propose the repurposing of anti-malarial drug mefloquine to fight the novel coronavirus
Study: Plastic better than cloth for low birth-weight newborns
Working out just five minutes daily via a practice described as “strength training for your breathing muscles” lowers blood pressure and improves some measures of vascular health as well as, or even more than, aerobic exercise or medication, new CU Boulder research shows.